We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which resolved at testing 12 weeks after initial presentation. Studying cases of pulmonary embolism and increased anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating the possible connection between severe acute respiratory syndrome coronavirus 2 infection, anti-phospholipid antibodies, and thrombosis.
All Keywords
【저자키워드】 COVID-19, Venous Thromboembolism, Anti-phospholipid antibodies, b-cell proliferation, 【초록키워드】 coronavirus disease, antibodies, coronavirus, thrombosis, antibody, Infection, Patient, Leukocytosis, connection, acute respiratory syndrome, Factor, acute pulmonary embolism, initial, resolved, 【제목키워드】 Transient,
【저자키워드】 COVID-19, Venous Thromboembolism, Anti-phospholipid antibodies, b-cell proliferation, 【초록키워드】 coronavirus disease, antibodies, coronavirus, thrombosis, antibody, Infection, Patient, Leukocytosis, connection, acute respiratory syndrome, Factor, acute pulmonary embolism, initial, resolved, 【제목키워드】 Transient,